nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—CYP1A2—Pentoxifylline—systemic scleroderma	0.0918	0.168	CbGbCtD
Ciprofloxacin—CYP1A2—Leflunomide—systemic scleroderma	0.0875	0.16	CbGbCtD
Ciprofloxacin—ABCB1—Lisinopril—systemic scleroderma	0.0802	0.147	CbGbCtD
Ciprofloxacin—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0727	0.133	CbGbCtD
Ciprofloxacin—ABCB1—Captopril—systemic scleroderma	0.0601	0.11	CbGbCtD
Ciprofloxacin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0473	0.0864	CbGbCtD
Ciprofloxacin—ABCB1—Prednisone—systemic scleroderma	0.0378	0.0691	CbGbCtD
Ciprofloxacin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0283	0.0518	CbGbCtD
Ciprofloxacin—CYP3A4—Prednisone—systemic scleroderma	0.0227	0.0414	CbGbCtD
Ciprofloxacin—ABCB1—Methotrexate—systemic scleroderma	0.019	0.0347	CbGbCtD
Ciprofloxacin—TOP2A—Methyltestosterone—Prednisone—systemic scleroderma	0.000696	1	CbGdCrCtD
Ciprofloxacin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000321	CcSEcCtD
Ciprofloxacin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000145	0.00032	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000145	0.00032	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000145	0.00032	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000144	0.00032	CcSEcCtD
Ciprofloxacin—Insomnia—Lisinopril—systemic scleroderma	0.000144	0.000319	CcSEcCtD
Ciprofloxacin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000318	CcSEcCtD
Ciprofloxacin—Paraesthesia—Lisinopril—systemic scleroderma	0.000143	0.000316	CcSEcCtD
Ciprofloxacin—Vomiting—Captopril—systemic scleroderma	0.000143	0.000316	CcSEcCtD
Ciprofloxacin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000315	CcSEcCtD
Ciprofloxacin—Dyspnoea—Lisinopril—systemic scleroderma	0.000142	0.000314	CcSEcCtD
Ciprofloxacin—Rash—Captopril—systemic scleroderma	0.000142	0.000314	CcSEcCtD
Ciprofloxacin—Dermatitis—Captopril—systemic scleroderma	0.000142	0.000313	CcSEcCtD
Ciprofloxacin—Somnolence—Lisinopril—systemic scleroderma	0.000142	0.000313	CcSEcCtD
Ciprofloxacin—Headache—Captopril—systemic scleroderma	0.000141	0.000312	CcSEcCtD
Ciprofloxacin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000311	CcSEcCtD
Ciprofloxacin—Dyspepsia—Lisinopril—systemic scleroderma	0.00014	0.00031	CcSEcCtD
Ciprofloxacin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00014	0.000309	CcSEcCtD
Ciprofloxacin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00014	0.000309	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000309	CcSEcCtD
Ciprofloxacin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000309	CcSEcCtD
Ciprofloxacin—Asthma—Methotrexate—systemic scleroderma	0.000139	0.000307	CcSEcCtD
Ciprofloxacin—Decreased appetite—Lisinopril—systemic scleroderma	0.000138	0.000306	CcSEcCtD
Ciprofloxacin—Eosinophilia—Methotrexate—systemic scleroderma	0.000138	0.000304	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000137	0.000304	CcSEcCtD
Ciprofloxacin—Fatigue—Lisinopril—systemic scleroderma	0.000137	0.000304	CcSEcCtD
Ciprofloxacin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000304	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000303	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000302	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000136	0.000302	CcSEcCtD
Ciprofloxacin—Pancreatitis—Methotrexate—systemic scleroderma	0.000136	0.000301	CcSEcCtD
Ciprofloxacin—Pain—Lisinopril—systemic scleroderma	0.000136	0.000301	CcSEcCtD
Ciprofloxacin—Constipation—Lisinopril—systemic scleroderma	0.000136	0.000301	CcSEcCtD
Ciprofloxacin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000301	CcSEcCtD
Ciprofloxacin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000135	0.0003	CcSEcCtD
Ciprofloxacin—Bradycardia—Prednisone—systemic scleroderma	0.000135	0.0003	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000298	CcSEcCtD
Ciprofloxacin—Diarrhoea—Azathioprine—systemic scleroderma	0.000134	0.000297	CcSEcCtD
Ciprofloxacin—Haemoglobin—Prednisone—systemic scleroderma	0.000134	0.000296	CcSEcCtD
Ciprofloxacin—Nausea—Captopril—systemic scleroderma	0.000134	0.000295	CcSEcCtD
Ciprofloxacin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000133	0.000295	CcSEcCtD
Ciprofloxacin—Haemorrhage—Prednisone—systemic scleroderma	0.000133	0.000294	CcSEcCtD
Ciprofloxacin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000294	CcSEcCtD
Ciprofloxacin—Asthenia—Leflunomide—systemic scleroderma	0.000133	0.000294	CcSEcCtD
Ciprofloxacin—Hallucination—Prednisone—systemic scleroderma	0.000132	0.000293	CcSEcCtD
Ciprofloxacin—Pancytopenia—Methotrexate—systemic scleroderma	0.000132	0.000292	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000131	0.00029	CcSEcCtD
Ciprofloxacin—Pruritus—Leflunomide—systemic scleroderma	0.000131	0.00029	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000131	0.000289	CcSEcCtD
Ciprofloxacin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000288	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00013	0.000288	CcSEcCtD
Ciprofloxacin—Dysuria—Methotrexate—systemic scleroderma	0.00013	0.000287	CcSEcCtD
Ciprofloxacin—Neutropenia—Methotrexate—systemic scleroderma	0.00013	0.000287	CcSEcCtD
Ciprofloxacin—Dizziness—Azathioprine—systemic scleroderma	0.00013	0.000287	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000281	CcSEcCtD
Ciprofloxacin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000127	0.000281	CcSEcCtD
Ciprofloxacin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000127	0.000281	CcSEcCtD
Ciprofloxacin—Diarrhoea—Leflunomide—systemic scleroderma	0.000127	0.00028	CcSEcCtD
Ciprofloxacin—Urticaria—Lisinopril—systemic scleroderma	0.000126	0.00028	CcSEcCtD
Ciprofloxacin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000279	CcSEcCtD
Ciprofloxacin—Abdominal pain—Lisinopril—systemic scleroderma	0.000126	0.000278	CcSEcCtD
Ciprofloxacin—Body temperature increased—Lisinopril—systemic scleroderma	0.000126	0.000278	CcSEcCtD
Ciprofloxacin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000277	CcSEcCtD
Ciprofloxacin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000125	0.000277	CcSEcCtD
Ciprofloxacin—Vomiting—Azathioprine—systemic scleroderma	0.000125	0.000276	CcSEcCtD
Ciprofloxacin—Pneumonia—Methotrexate—systemic scleroderma	0.000125	0.000276	CcSEcCtD
Ciprofloxacin—Eye disorder—Prednisone—systemic scleroderma	0.000124	0.000275	CcSEcCtD
Ciprofloxacin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000275	CcSEcCtD
Ciprofloxacin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000274	CcSEcCtD
Ciprofloxacin—Infestation—Methotrexate—systemic scleroderma	0.000124	0.000274	CcSEcCtD
Ciprofloxacin—Drowsiness—Methotrexate—systemic scleroderma	0.000124	0.000274	CcSEcCtD
Ciprofloxacin—Infestation NOS—Methotrexate—systemic scleroderma	0.000124	0.000274	CcSEcCtD
Ciprofloxacin—Rash—Azathioprine—systemic scleroderma	0.000124	0.000274	CcSEcCtD
Ciprofloxacin—Dermatitis—Azathioprine—systemic scleroderma	0.000124	0.000273	CcSEcCtD
Ciprofloxacin—Depression—Methotrexate—systemic scleroderma	0.000124	0.000273	CcSEcCtD
Ciprofloxacin—Flushing—Prednisone—systemic scleroderma	0.000123	0.000273	CcSEcCtD
Ciprofloxacin—Headache—Azathioprine—systemic scleroderma	0.000123	0.000272	CcSEcCtD
Ciprofloxacin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000123	0.000272	CcSEcCtD
Ciprofloxacin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000272	CcSEcCtD
Ciprofloxacin—Dizziness—Leflunomide—systemic scleroderma	0.000123	0.000271	CcSEcCtD
Ciprofloxacin—Renal failure—Methotrexate—systemic scleroderma	0.000122	0.000269	CcSEcCtD
Ciprofloxacin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000268	CcSEcCtD
Ciprofloxacin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000121	0.000268	CcSEcCtD
Ciprofloxacin—Stomatitis—Methotrexate—systemic scleroderma	0.000121	0.000267	CcSEcCtD
Ciprofloxacin—Angiopathy—Prednisone—systemic scleroderma	0.000121	0.000267	CcSEcCtD
Ciprofloxacin—Conjunctivitis—Methotrexate—systemic scleroderma	0.00012	0.000266	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000266	CcSEcCtD
Ciprofloxacin—Immune system disorder—Prednisone—systemic scleroderma	0.00012	0.000266	CcSEcCtD
Ciprofloxacin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000264	CcSEcCtD
Ciprofloxacin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000264	CcSEcCtD
Ciprofloxacin—Arrhythmia—Prednisone—systemic scleroderma	0.000119	0.000263	CcSEcCtD
Ciprofloxacin—Sweating—Methotrexate—systemic scleroderma	0.000119	0.000263	CcSEcCtD
Ciprofloxacin—Haematuria—Methotrexate—systemic scleroderma	0.000118	0.000261	CcSEcCtD
Ciprofloxacin—Vomiting—Leflunomide—systemic scleroderma	0.000118	0.000261	CcSEcCtD
Ciprofloxacin—Alopecia—Prednisone—systemic scleroderma	0.000118	0.00026	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000117	0.000259	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000117	0.000259	CcSEcCtD
Ciprofloxacin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000117	0.000259	CcSEcCtD
Ciprofloxacin—Epistaxis—Methotrexate—systemic scleroderma	0.000117	0.000259	CcSEcCtD
Ciprofloxacin—Rash—Leflunomide—systemic scleroderma	0.000117	0.000258	CcSEcCtD
Ciprofloxacin—Dermatitis—Leflunomide—systemic scleroderma	0.000117	0.000258	CcSEcCtD
Ciprofloxacin—Mental disorder—Prednisone—systemic scleroderma	0.000117	0.000258	CcSEcCtD
Ciprofloxacin—Nausea—Azathioprine—systemic scleroderma	0.000117	0.000258	CcSEcCtD
Ciprofloxacin—Headache—Leflunomide—systemic scleroderma	0.000116	0.000257	CcSEcCtD
Ciprofloxacin—Malnutrition—Prednisone—systemic scleroderma	0.000116	0.000256	CcSEcCtD
Ciprofloxacin—Erythema—Prednisone—systemic scleroderma	0.000116	0.000256	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000116	0.000256	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000115	0.000254	CcSEcCtD
Ciprofloxacin—Asthenia—Lisinopril—systemic scleroderma	0.000114	0.000253	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000252	CcSEcCtD
Ciprofloxacin—Pruritus—Lisinopril—systemic scleroderma	0.000113	0.000249	CcSEcCtD
Ciprofloxacin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000112	0.000249	CcSEcCtD
Ciprofloxacin—Haemoglobin—Methotrexate—systemic scleroderma	0.000112	0.000247	CcSEcCtD
Ciprofloxacin—Rash—Mycophenolic acid—systemic scleroderma	0.000111	0.000247	CcSEcCtD
Ciprofloxacin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000111	0.000246	CcSEcCtD
Ciprofloxacin—Haemorrhage—Methotrexate—systemic scleroderma	0.000111	0.000246	CcSEcCtD
Ciprofloxacin—Hepatitis—Methotrexate—systemic scleroderma	0.000111	0.000246	CcSEcCtD
Ciprofloxacin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000245	CcSEcCtD
Ciprofloxacin—Headache—Mycophenolic acid—systemic scleroderma	0.000111	0.000245	CcSEcCtD
Ciprofloxacin—Pharyngitis—Methotrexate—systemic scleroderma	0.00011	0.000244	CcSEcCtD
Ciprofloxacin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000244	CcSEcCtD
Ciprofloxacin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000244	CcSEcCtD
Ciprofloxacin—Nausea—Leflunomide—systemic scleroderma	0.00011	0.000243	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00011	0.000243	CcSEcCtD
Ciprofloxacin—Vision blurred—Prednisone—systemic scleroderma	0.000109	0.000242	CcSEcCtD
Ciprofloxacin—Urethral disorder—Methotrexate—systemic scleroderma	0.000109	0.000241	CcSEcCtD
Ciprofloxacin—Diarrhoea—Lisinopril—systemic scleroderma	0.000109	0.000241	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000107	0.000238	CcSEcCtD
Ciprofloxacin—Visual impairment—Methotrexate—systemic scleroderma	0.000107	0.000237	CcSEcCtD
Ciprofloxacin—Anaemia—Prednisone—systemic scleroderma	0.000107	0.000237	CcSEcCtD
Ciprofloxacin—Agitation—Prednisone—systemic scleroderma	0.000106	0.000236	CcSEcCtD
Ciprofloxacin—Angioedema—Prednisone—systemic scleroderma	0.000106	0.000234	CcSEcCtD
Ciprofloxacin—Dizziness—Lisinopril—systemic scleroderma	0.000105	0.000233	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000105	0.000233	CcSEcCtD
Ciprofloxacin—Nausea—Mycophenolic acid—systemic scleroderma	0.000105	0.000232	CcSEcCtD
Ciprofloxacin—Malaise—Prednisone—systemic scleroderma	0.000104	0.000231	CcSEcCtD
Ciprofloxacin—Vertigo—Prednisone—systemic scleroderma	0.000104	0.00023	CcSEcCtD
Ciprofloxacin—Eye disorder—Methotrexate—systemic scleroderma	0.000104	0.00023	CcSEcCtD
Ciprofloxacin—Syncope—Prednisone—systemic scleroderma	0.000104	0.00023	CcSEcCtD
Ciprofloxacin—Tinnitus—Methotrexate—systemic scleroderma	0.000104	0.000229	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000103	0.000228	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000227	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Prednisone—systemic scleroderma	0.000102	0.000225	CcSEcCtD
Ciprofloxacin—Vomiting—Lisinopril—systemic scleroderma	0.000101	0.000224	CcSEcCtD
Ciprofloxacin—Angiopathy—Methotrexate—systemic scleroderma	0.000101	0.000223	CcSEcCtD
Ciprofloxacin—Immune system disorder—Methotrexate—systemic scleroderma	0.0001	0.000222	CcSEcCtD
Ciprofloxacin—Rash—Lisinopril—systemic scleroderma	0.0001	0.000222	CcSEcCtD
Ciprofloxacin—Convulsion—Prednisone—systemic scleroderma	0.0001	0.000222	CcSEcCtD
Ciprofloxacin—Dermatitis—Lisinopril—systemic scleroderma	0.0001	0.000222	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.0001	0.000222	CcSEcCtD
Ciprofloxacin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000221	CcSEcCtD
Ciprofloxacin—Hypertension—Prednisone—systemic scleroderma	0.0001	0.000221	CcSEcCtD
Ciprofloxacin—Chills—Methotrexate—systemic scleroderma	9.98e-05	0.000221	CcSEcCtD
Ciprofloxacin—Headache—Lisinopril—systemic scleroderma	9.97e-05	0.000221	CcSEcCtD
Ciprofloxacin—Pruritus—Mycophenolate mofetil—systemic scleroderma	9.87e-05	0.000218	CcSEcCtD
Ciprofloxacin—Arthralgia—Prednisone—systemic scleroderma	9.86e-05	0.000218	CcSEcCtD
Ciprofloxacin—Myalgia—Prednisone—systemic scleroderma	9.86e-05	0.000218	CcSEcCtD
Ciprofloxacin—Anxiety—Prednisone—systemic scleroderma	9.83e-05	0.000217	CcSEcCtD
Ciprofloxacin—Alopecia—Methotrexate—systemic scleroderma	9.83e-05	0.000217	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	9.79e-05	0.000217	CcSEcCtD
Ciprofloxacin—Discomfort—Prednisone—systemic scleroderma	9.74e-05	0.000216	CcSEcCtD
Ciprofloxacin—Mental disorder—Methotrexate—systemic scleroderma	9.74e-05	0.000216	CcSEcCtD
Ciprofloxacin—Erythema—Methotrexate—systemic scleroderma	9.68e-05	0.000214	CcSEcCtD
Ciprofloxacin—Malnutrition—Methotrexate—systemic scleroderma	9.68e-05	0.000214	CcSEcCtD
Ciprofloxacin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	9.54e-05	0.000211	CcSEcCtD
Ciprofloxacin—Dysgeusia—Methotrexate—systemic scleroderma	9.48e-05	0.00021	CcSEcCtD
Ciprofloxacin—Nausea—Lisinopril—systemic scleroderma	9.45e-05	0.000209	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Prednisone—systemic scleroderma	9.45e-05	0.000209	CcSEcCtD
Ciprofloxacin—Oedema—Prednisone—systemic scleroderma	9.45e-05	0.000209	CcSEcCtD
Ciprofloxacin—Back pain—Methotrexate—systemic scleroderma	9.36e-05	0.000207	CcSEcCtD
Ciprofloxacin—Shock—Prednisone—systemic scleroderma	9.3e-05	0.000206	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Prednisone—systemic scleroderma	9.27e-05	0.000205	CcSEcCtD
Ciprofloxacin—Tachycardia—Prednisone—systemic scleroderma	9.23e-05	0.000204	CcSEcCtD
Ciprofloxacin—Dizziness—Mycophenolate mofetil—systemic scleroderma	9.22e-05	0.000204	CcSEcCtD
Ciprofloxacin—Skin disorder—Prednisone—systemic scleroderma	9.18e-05	0.000203	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Prednisone—systemic scleroderma	9.14e-05	0.000202	CcSEcCtD
Ciprofloxacin—Vision blurred—Methotrexate—systemic scleroderma	9.12e-05	0.000202	CcSEcCtD
Ciprofloxacin—Anorexia—Prednisone—systemic scleroderma	9.01e-05	0.000199	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Methotrexate—systemic scleroderma	8.98e-05	0.000199	CcSEcCtD
Ciprofloxacin—Anaemia—Methotrexate—systemic scleroderma	8.95e-05	0.000198	CcSEcCtD
Ciprofloxacin—Vomiting—Mycophenolate mofetil—systemic scleroderma	8.87e-05	0.000196	CcSEcCtD
Ciprofloxacin—Rash—Mycophenolate mofetil—systemic scleroderma	8.79e-05	0.000195	CcSEcCtD
Ciprofloxacin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	8.79e-05	0.000194	CcSEcCtD
Ciprofloxacin—Headache—Mycophenolate mofetil—systemic scleroderma	8.74e-05	0.000193	CcSEcCtD
Ciprofloxacin—Malaise—Methotrexate—systemic scleroderma	8.73e-05	0.000193	CcSEcCtD
Ciprofloxacin—Vertigo—Methotrexate—systemic scleroderma	8.7e-05	0.000192	CcSEcCtD
Ciprofloxacin—Leukopenia—Methotrexate—systemic scleroderma	8.67e-05	0.000192	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	8.61e-05	0.000191	CcSEcCtD
Ciprofloxacin—Insomnia—Prednisone—systemic scleroderma	8.55e-05	0.000189	CcSEcCtD
Ciprofloxacin—Paraesthesia—Prednisone—systemic scleroderma	8.49e-05	0.000188	CcSEcCtD
Ciprofloxacin—Cough—Methotrexate—systemic scleroderma	8.45e-05	0.000187	CcSEcCtD
Ciprofloxacin—Convulsion—Methotrexate—systemic scleroderma	8.39e-05	0.000186	CcSEcCtD
Ciprofloxacin—Dyspepsia—Prednisone—systemic scleroderma	8.32e-05	0.000184	CcSEcCtD
Ciprofloxacin—Nausea—Mycophenolate mofetil—systemic scleroderma	8.28e-05	0.000183	CcSEcCtD
Ciprofloxacin—Chest pain—Methotrexate—systemic scleroderma	8.24e-05	0.000182	CcSEcCtD
Ciprofloxacin—Myalgia—Methotrexate—systemic scleroderma	8.24e-05	0.000182	CcSEcCtD
Ciprofloxacin—Arthralgia—Methotrexate—systemic scleroderma	8.24e-05	0.000182	CcSEcCtD
Ciprofloxacin—Decreased appetite—Prednisone—systemic scleroderma	8.22e-05	0.000182	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.19e-05	0.000181	CcSEcCtD
Ciprofloxacin—Fatigue—Prednisone—systemic scleroderma	8.15e-05	0.00018	CcSEcCtD
Ciprofloxacin—Discomfort—Methotrexate—systemic scleroderma	8.14e-05	0.00018	CcSEcCtD
Ciprofloxacin—Constipation—Prednisone—systemic scleroderma	8.08e-05	0.000179	CcSEcCtD
Ciprofloxacin—Confusional state—Methotrexate—systemic scleroderma	7.97e-05	0.000176	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Methotrexate—systemic scleroderma	7.9e-05	0.000175	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Prednisone—systemic scleroderma	7.79e-05	0.000172	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Methotrexate—systemic scleroderma	7.75e-05	0.000171	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Methotrexate—systemic scleroderma	7.74e-05	0.000171	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Prednisone—systemic scleroderma	7.73e-05	0.000171	CcSEcCtD
Ciprofloxacin—Skin disorder—Methotrexate—systemic scleroderma	7.67e-05	0.00017	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Methotrexate—systemic scleroderma	7.64e-05	0.000169	CcSEcCtD
Ciprofloxacin—Anorexia—Methotrexate—systemic scleroderma	7.53e-05	0.000167	CcSEcCtD
Ciprofloxacin—Urticaria—Prednisone—systemic scleroderma	7.51e-05	0.000166	CcSEcCtD
Ciprofloxacin—Body temperature increased—Prednisone—systemic scleroderma	7.47e-05	0.000165	CcSEcCtD
Ciprofloxacin—Abdominal pain—Prednisone—systemic scleroderma	7.47e-05	0.000165	CcSEcCtD
Ciprofloxacin—Hypotension—Methotrexate—systemic scleroderma	7.38e-05	0.000163	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.2e-05	0.000159	CcSEcCtD
Ciprofloxacin—Insomnia—Methotrexate—systemic scleroderma	7.15e-05	0.000158	CcSEcCtD
Ciprofloxacin—Paraesthesia—Methotrexate—systemic scleroderma	7.09e-05	0.000157	CcSEcCtD
Ciprofloxacin—Dyspnoea—Methotrexate—systemic scleroderma	7.04e-05	0.000156	CcSEcCtD
Ciprofloxacin—Somnolence—Methotrexate—systemic scleroderma	7.02e-05	0.000155	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Prednisone—systemic scleroderma	6.97e-05	0.000154	CcSEcCtD
Ciprofloxacin—Dyspepsia—Methotrexate—systemic scleroderma	6.95e-05	0.000154	CcSEcCtD
Ciprofloxacin—Decreased appetite—Methotrexate—systemic scleroderma	6.87e-05	0.000152	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	6.82e-05	0.000151	CcSEcCtD
Ciprofloxacin—Fatigue—Methotrexate—systemic scleroderma	6.81e-05	0.000151	CcSEcCtD
Ciprofloxacin—Asthenia—Prednisone—systemic scleroderma	6.78e-05	0.00015	CcSEcCtD
Ciprofloxacin—Pain—Methotrexate—systemic scleroderma	6.76e-05	0.000149	CcSEcCtD
Ciprofloxacin—Pruritus—Prednisone—systemic scleroderma	6.69e-05	0.000148	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Methotrexate—systemic scleroderma	6.51e-05	0.000144	CcSEcCtD
Ciprofloxacin—Diarrhoea—Prednisone—systemic scleroderma	6.47e-05	0.000143	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.46e-05	0.000143	CcSEcCtD
Ciprofloxacin—Urticaria—Methotrexate—systemic scleroderma	6.28e-05	0.000139	CcSEcCtD
Ciprofloxacin—Dizziness—Prednisone—systemic scleroderma	6.25e-05	0.000138	CcSEcCtD
Ciprofloxacin—Abdominal pain—Methotrexate—systemic scleroderma	6.25e-05	0.000138	CcSEcCtD
Ciprofloxacin—Body temperature increased—Methotrexate—systemic scleroderma	6.25e-05	0.000138	CcSEcCtD
Ciprofloxacin—Vomiting—Prednisone—systemic scleroderma	6.01e-05	0.000133	CcSEcCtD
Ciprofloxacin—Rash—Prednisone—systemic scleroderma	5.96e-05	0.000132	CcSEcCtD
Ciprofloxacin—Dermatitis—Prednisone—systemic scleroderma	5.96e-05	0.000132	CcSEcCtD
Ciprofloxacin—Headache—Prednisone—systemic scleroderma	5.92e-05	0.000131	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Methotrexate—systemic scleroderma	5.82e-05	0.000129	CcSEcCtD
Ciprofloxacin—Asthenia—Methotrexate—systemic scleroderma	5.67e-05	0.000125	CcSEcCtD
Ciprofloxacin—Nausea—Prednisone—systemic scleroderma	5.62e-05	0.000124	CcSEcCtD
Ciprofloxacin—Pruritus—Methotrexate—systemic scleroderma	5.59e-05	0.000124	CcSEcCtD
Ciprofloxacin—Diarrhoea—Methotrexate—systemic scleroderma	5.41e-05	0.00012	CcSEcCtD
Ciprofloxacin—Dizziness—Methotrexate—systemic scleroderma	5.22e-05	0.000116	CcSEcCtD
Ciprofloxacin—Vomiting—Methotrexate—systemic scleroderma	5.02e-05	0.000111	CcSEcCtD
Ciprofloxacin—Rash—Methotrexate—systemic scleroderma	4.98e-05	0.00011	CcSEcCtD
Ciprofloxacin—Dermatitis—Methotrexate—systemic scleroderma	4.98e-05	0.00011	CcSEcCtD
Ciprofloxacin—Headache—Methotrexate—systemic scleroderma	4.95e-05	0.00011	CcSEcCtD
Ciprofloxacin—Nausea—Methotrexate—systemic scleroderma	4.69e-05	0.000104	CcSEcCtD
